Skip to main content

New Products

  • Bayer HealthCare gains orphan drug designation for investigational Ciprofloxacin Dry Powder

    WHIPPANY, N.J. — Bayer HealthCare on Tuesday announced that the Food and Drug Administration's Office of Orphan Products Development has granted orphan drug designation for Bayer's investigational Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) for the treatment of non-cystic fibrosis bronchiectasis. Patients with NCFB suffer from frequent severe acute pulmonary bacterial exacerbations, which lead to further inflammation, airway and lung parenchyma damage.

  • Prettie Girls! take a bow at H-E-B

    HOUSTON — Last weekend marked the in-store retail debut of the Prettie Girls!, a line of multicultural dolls, at H-E-B stores. The dolls were well-received by customers and sold out completely after just a few hours, the grocer said.

  • Dr. Reddy's launches generic Antara capsules

    HYDERABAD, India — Dr. Reddy's Labs on Wednesday announced the launch of fenofibrate capsules, USP in 43-mg and 130-mg strengths. The drug is the generic version of Antara (fenofibrate) capsules.

    The Antara capsules brand and generics had U.S. sales of approximately $74 million MAT for the most recent 12 months ending February 2014, according to IMS Health. Dr. Reddy's fenofibrate capsules, USP 43-mg is available in bottle counts of 30; 130-mg are available in bottle counts of 30 and 90.

     

  • Cefaly makes Rx medical device for the preventive treatment of migraine headaches available online

    NEW YORK — Cefaly Technology announced Wednesday that the Cefaly medical device for the preventive treatment of migraine headaches is available for purchase and delivery in the United States for patients with a medical prescription at Cefaly.us.

    The company that manufactures Cefaly expects to make the device available via select pharmacies and clinics in the months ahead. 

  • Dry Idea launches new StainClear formulation

    SCOTTSDALE, Ariz. — Henkel’s Dry Idea brand has introduced its new Dry Idea Stain Clear.

    The new invisible solid goes on clear and combines stain fighting technology with wetness protection and 72-hour odor coverage, the company stated.

  • PepsiCo adds twisted new addition

    PLANO, Texas — PepsiCo on Tuesday announced the debut of new Twistos Baked Snack Bites to its portfolio. The bites are available in three flavors — bruschetta, parmesan and garlic, and asiago flavors — and can be enjoyed as a standalone snackng item, or as complement to a soup or salad, the company said.

    The brand has teamed up with chef and food writer Gaby Dalkin of "What's Gaby Cooking" to help develop tips for mixing up snack time.

  • NBTY launches new supplement line

    RONKONKOMA, N.Y. — NBTY, a global manufacturer and distributor or vitamins and nutritional supplements, introduced Nature's Origin, the company's first complete line of vitamins, minerals and herbal supplements. The products are available in the United States direct to consumers at NaturesOrigin.com.

  • FDA approves Eli Lilly orphan drug for gastric cancer

    INDIANAPOLIS — Eli Lilly on Monday announced that the Food and Drug Administration has approved Cyramza (ramucirumab) as a single-agent treatment for patients with advanced or metastatic gastric cancer or gastroesophageal junction adenocarcinoma with disease progression on or after prior fluoropyrimidine- or platinum-containing chemotherapy. With this approval, Cyramza becomes the first FDA-approved treatment for patients in this setting.

X
This ad will auto-close in 10 seconds